Skip to main content

Table 1 Baseline characteristics of patients with chemotherapy and no-chemotherapy

From: The impact of chemotherapy and survival prediction by machine learning in early Elderly Triple Negative Breast Cancer (eTNBC): a population based study from the SEER database

Characteristics

No-Chemotherapy (n = 2574)

Chemotherapy (n = 2122)

Total (n = 4696)

Pc

No

%

No

%

No

%

Median follow-up (months) (IQR)

27(12–49)

27(12–47)

27(12–48)

 

Age (years)

70–79

1257

48.8

1836

86.5

3093

65.9

 < 0.001

80 + 

1317

51.2

286

13.5

1603

34.1

 

Race

White

2003

77.8

1636

77.1

3639

77.5

0.238

Black

383

14.9

348

16.4

731

15.6

 

Othera

188

7.3

138

6.5

326

6.9

 

Marital status

Married

959

37.3

1085

51.1

2044

43.5

 < 0.001

Not marriedb

1615

62.7

1037

48.9

2652

56.5

 

Grade

I and II

707

27.5

388

18.3

1095

23.3

 < 0.001

III

1867

72.5

1734

81,7

3601

76.7

 

AJCC stage

I

1317

51.2

706

33.3

2023

43.1

 < 0.001

II

960

37.3

999

47.1

1959

41.7

 

III

297

11.5

417

8.9

714

15.2

 

Tumor status

T1

1435

55.7

910

42.9

2345

49.9

 < 0.001

T2

876

34.0

919

43.3

1795

38.2

 

T3

150

5.8

148

7.0

298

6.3

 

T4

113

4.4

145

6.8

258

5.5

 

Nodal status

N0

2039

79.2

1290

60.8

3329

70.9

 < 0.001

N1

357

13.9

556

26.2

913

19.4

 

N2

104

4.0

172

8.1

276

5.9

 

N3

74

2.9

104

4.9

178

3.8

 

Surgery approach

No surgery

150

5.8

107

5.0

257

5.5

0.239

 

Mastectomy and BCS

2424

94.2

2015

95.0

4439

94.5

 

Radiation status

Yes

1013

39.4

1179

55.6

2192

46.7

 < 0.001

 

No

1561

60.6

943

44.4

2504

53.3

 
  1. Abbreviation: AJCC American Joint Committee on Cancer, BCS Breast-conserving surgery, IQR Interquartile range
  2. aOther includes American Indian/Alaskan native and Asian/Pacific Islander and Unknown
  3. bNot married includes divorced, separated, single (never married), unmarried or domestic partner, and widowed
  4. cThe P value of the Chi-square test was calculated between the chemotherapy and no-chemotherapy groups, and bold type indicates significance